16 April 2024 | Tuesday | News
Photo Courtesy | BioPharma BoardRoom
Cytiva, a global leader in life sciences solutions, proudly announces its participation at INTERPHEX 2024, where it will unveil its latest advancements in bioprocessing technology. With a commitment to revolutionizing the way biopharmaceuticals are developed and produced, Cytiva's showcase promises to set new standards in efficiency, quality, and sustainability within the industry.
At INTERPHEX 2024, Cytiva will showcase:
Next-Generation Bioreactors: Experience firsthand Cytiva's innovative bioreactor systems designed to optimize cell culture processes, enabling faster production and improved yield of biopharmaceuticals.
Integrated Solutions for Continuous Manufacturing: Witness Cytiva's integrated platforms that seamlessly combine upstream and downstream processes, empowering manufacturers to achieve continuous bioprocessing and accelerate time-to-market.
Advanced Chromatography Technologies: Explore Cytiva's latest chromatography solutions, engineered to enhance purification efficiency, reduce costs, and ensure the highest product purity for biopharmaceutical production.
Digital Transformation in Bioprocessing: Learn about Cytiva's digital solutions that leverage cutting-edge analytics, automation, and data integration to streamline bioprocess development and optimize manufacturing operations.
Sustainable Manufacturing Initiatives: Discover Cytiva's commitment to sustainability through innovative technologies and initiatives aimed at reducing environmental impact and promoting eco-friendly bioprocessing solutions.
"We are excited to showcase our latest innovations at INTERPHEX 2024, reinforcing Cytiva's dedication to advancing bioprocessing technology and driving positive change in the life sciences industry," said Spokesperson's at Cytiva. "Through collaboration and innovation, we continue to empower our customers to overcome challenges and achieve their goals in biopharmaceutical development and manufacturing."
Visit Cytiva at INTERPHEX 2024
© 2025 Biopharma Boardroom. All Rights Reserved.